Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 237-864-5
CAS number: 14025-15-1
One chronic study is available with
EDTA-CaNa2 in rats, and two supporting chronic studies are available
with EDTA-Na3H in rats and mice, respectively (see also read across
document in section 13).
Because no treatment-related tumours have
been observed following chronic exposure to EDTA-CaNa2, and no
treatment-related tumours have been observed following chronic exposure
to EDTA-Na3H, and no such effects are expected for EDTA-CuNa2, this
substance does not need classification for this endpoint.
No treatment-related tumours were observed
following chronic exposure to either EDTA-CaNa2 or EDTA-Na3H. In
addition, other chelates did not demonstrate any pre-neoplastic or
neoplastic lesions in repeated dose toxicity studies.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again